A Prospective Analysis of the Metyrapone Short Test Using Targeted and Untargeted Metabolomics.
Seoudy AK, Schlicht K, Kulle A, Demetrowitsch T, Beckmann A, Geisler C, Türk K, Rohmann N, Hartmann K, Brandes J, Schulte DM, Schreiber S, Schwarz K, Holterhus PM, Laudes M.
Seoudy AK, et al. Among authors: kulle a.
Neuroendocrinology. 2023;113(7):770-784. doi: 10.1159/000529146. Epub 2023 Jan 16.
Neuroendocrinology. 2023.
PMID: 36646062